It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Tissue mechanics determines tissue homeostasis, disease development and progression. Bladder strongly relies on its mechanical properties to perform its physiological function, but these are poorly unveiled under normal and pathological conditions. Here we characterize the mechanical fingerprints at the micro-scale level of the three tissue layers which compose the healthy bladder wall, and identify modifications associated with the onset and progression of pathological conditions (i.e., actinic cystitis and bladder cancer). We use two indentation-based instruments (an Atomic Force Microscope and a nanoindenter) and compare the micromechanical maps with a comprehensive histological analysis. We find that the healthy bladder wall is a mechanically inhomogeneous tissue, with a gradient of increasing stiffness from the urothelium to the lamina propria, which gradually decreases when reaching the muscle outer layer. Stiffening in fibrotic tissues correlate with increased deposition of dense extracellular matrix in the lamina propria. An increase in tissue compliance is observed before the onset and invasion of the tumor. By providing high resolution micromechanical investigation of each tissue layer of the bladder, we depict the intrinsic mechanical heterogeneity of the layers of a healthy bladder as compared with the mechanical properties alterations associated with either actinic cystitis or bladder tumor.
The micromechanical fingerprints of bladders in rats change following actinic cystitis or in the presence of bladder tumours.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884); Università Vita-Salute San Raffaele, Milan, Italy (GRID:grid.15496.3f) (ISNI:0000 0001 0439 0892)
2 Università degli Studi di Milano, C.I.Ma.I.Na and Dipartimento di Fisica “Aldo Pontremoli”, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
3 Optics11, Amsterdam, The Netherlands (GRID:grid.4708.b); VU University, LaserLab, Department of Physics and Astronomy, Amsterdam, The Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227)
4 Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
5 Pathology Unit, IRCCS Ospedale San Raffaele, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
6 Optics11, Amsterdam, The Netherlands (GRID:grid.4708.b)